Apexigen
is a California-based biopharmaceutical company that researches and develops immuno-oncology therapeutics for the treatment of cancer... Read moreApexigen
is a California-based biopharmaceutical company that researches and develops immuno-oncology therapeutics for the treatment of cancer... Read more
News
Aug 25, 2023
MarketScreener
Apexigen: Apexigen, Inc.(NasdaqCM:APGN) dropped from S&P TMI Index
Aug 23, 2023
BioSpace
Apexigen: Pyxis Oncology Successfully Completes Acquisition of Apexigen
Aug 11, 2023
MarketScreener
Apexigen: SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, CPRI, APGN
Aug 11, 2023
MarketScreener
Apexigen: Pyxis Oncology : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K
Aug 10, 2023
MarketScreener
Apexigen: APEXIGEN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc. - APGN
Jun 03, 2023
Life Care News
Apexigen: Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its
May 31, 2023
MarketScreener
Apexigen: APEXIGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc. - APGN
May 25, 2023
Pharamceutical Technology
Apexigen: Pyxis Oncology signs agreement to buy Apexigen
Mar 01, 2023
Americanbankingnews
Apexigen: Apexigen, Inc. (NASDAQ:APGN) to Post Q4 2022 Earnings of ($0.32) Per Share, Brookline Capital Management Forecasts
Feb 27, 2023
Contract Pharma
Apexigen: Apexigen Announces Restructuring Strategy
Apexigen Competitors
1
2
3
4
5
6
7
8
9
10